Safety and efficacy of blinatumomab: a real world data
In conclusion, treatment with blinatumomab is effective and tolerable in adult patients with relapsed/refractory B-ALL outside of a clinical trial stetting.
Source: Annals of Hematology - Category: Hematology Source Type: research
More News: Acute Leukemia | Acute Lymphoblastic Leukemia | Brain | Chemotherapy | Clinical Trials | Hematology | Leukemia | Lymphoma | Neurology | Stem Cell Therapy | Stem Cells | Transplants